Faron, etusivu

releases and publications

Faron Pharmaceuticals Oy Harmful association of glucocorticoids in interferon beta-1a treated patients published in Intensive Care Medicine

Results of the Annual General Meeting

Regulatory

Exercise of options

Regulatory

Managers’ transactions

Insider Transaction Regulatory

Faron receives grant from Business Finland

Regulatory

Clevegen manufacturing agreement

Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Traumakine to be a part of WHO’s Solidarity trial

Regulatory

Update on results of Placing and issue of equity

Regulatory
PreviousNext
Back to top